4 completed, 1 recruiting. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Recruiting 1 |
Follow Opdivo: new trials by email Literature Review of Opdivo trials Research Report on Opdivo
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma Nivolumab, Cabozantinib - Kidney Cancer, Renal Cell Cancer | Phase 4 | Recruiting | Gustave Roussy, Cancer Campus, Grand Paris | 50 | 2025-05-16 | 2025-09-24 |
| A Study to Evaluate the Safety and Efficacy of Nivolumab With Ipilimumab in Participants With Untreated Advanced Kidney Cancer Conducted in India Nivolumab, Ipilimumab - Kidney Neoplasms | Phase 4 | Completed | Bristol-Myers Squibb | 101 | 2020-12-17 | 2025-07-11 |
| Study of Nivolumab for Advanced Cancers in India Nivolumab - Non-Small Cell Lung Cancer (NSCLC), Non-Small-Cell Lung Carcinoma | Phase 4 | Completed | Bristol-Myers Squibb | 100 | 2018-03-06 | 2020-12-04 |
| A Study to Evaluate the Safety of Nivolumab and Ipilimumab in Subjects With Previously Untreated Advanced or Metastatic Renal Cell Cancer Nivolumab, Ipilimumab - Renal Cell Carcinoma | Phase 4 | Completed | Bristol-Myers Squibb | 211 | 2017-01-16 | 2022-11-01 |
| An Investigational Immuno-therapy Safety Trial of Nivolumab in Patients With Advanced or Metastatic Renal Cell Carcinoma Nivolumab - Renal Cell Carcinoma | Phase 4 | Completed | Bristol-Myers Squibb | 197 | 2016-01-08 | 2022-10-27 |
Carcinoma, Renal Cell (3) · Kidney Neoplasms (3) · Carcinoma, Non-Small-Cell Lung (1)
Bristol-Myers Squibb (4) · Gustave Roussy, Cancer Campus, Grand Paris (1)
India (2) · United States (2) · France (1)
2015 (1)